FindTrial
Sign In

Effectiveness of ANI and SPI as a measure of pain in patients undergoing cystoscopic procedure under remifentanil infusion

A prospective observational study on the effectiveness of ANI and SPI as a measure of pain in patients undergoing cystoscopic procedure under remifentanil infusion

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008687
Enrollment
30
Registered
2023-08-07
Start date
2023-04-18
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Inje University Sanggye Paik Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients (> 18 years) undergoing cystoscopic procedure under monitored anesthetic care (remifentanil infusion)

Exclusion criteria

Exclusion criteria: - ASA physical status class 5 - Morbid obesity ( BMI =, >35) - Severe valvular heart disease - Arrhythmia such as atrial fibrillation - History of cardiac transplantation, Patients with cardiac pacemaker - CNS disorder, autonomic disease - Cognitive disorder including deliruim, dementia - Patients taking alpha-2 agonist, beta blockers, or antiarrhythmics - Patients chronically taking sedative hypnotics and narcotic analgesics - Patients who underwent nerve block for pain control - emergency surgery - Patients with mean BP below 60 mmHg and heart rate below 45 bpm and above 120 bpm on the morning of surgery - in case that investigators judge that it is inappropriate to participate in this study

Design outcomes

Primary

MeasureTime frame
ANI value, SPI value, pain scores (NRS)—

Secondary

MeasureTime frame
BP, HR, SpO2, RR—

Countries

Korea, Republic of

Contacts

Public ContactKye-Min Kim

Inje University Sanggye Paik Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026